🇺🇸 CYTK — Cytokinetics, Incorporated

Salud Compra fuerte
← Volver

Precio actual

55,55 USD

Máx. histórico

108,06

1032 días

Split 1:6 del 25/06/2013

Caída desde máximo

-48,59%

Rango 52 semanas

54,16 – 88,31

Variación hoy

-12,66%

Cierre anterior

63,60

Rango de hoy

54,16 – 60,84

Volumen hoy

6.774.495

Peor caída histórica

-97,06%

05/05/2004 → 10/10/2014

Recuperado en 3377 días

Volatilidad anualizada ⓘ

69,41%

Información
Nombre completo
Cytokinetics, Incorporated
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
673
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,39 USD (puede no estar actualizado)
Primera cotización
30/04/2004
Precio actualizado
hace 9 horas
Sobre la empresa

Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of HCM; and omecamtiv mecarbil, a potential treatment across the continuum of care in heart failure with severely reduced ejection fraction. In addition, the company is involved in developing and Ulacamten, a novel, selective, oral, and small molecule cardiac myosin inhibitor designed to reduce the hypercontractility associated with heart failure with preserved ejection fraction in Phase 1 clinical trials; and CK-089, a fast skeletal muscle troponin activator in Phase 1 clinical trials. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.

Splits Registrados en el histórico de precios
Fecha Ratio
25/06/2013 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
26/03/2021 24,08 24,65 22,97 23,87 -0,54% 6,98% 467.800
25/03/2021 22,01 24,25 22,01 24,00 +7,14% 10,18% 922.700
24/03/2021 23,87 24,69 22,39 22,40 -5,45% 9,64% 699.400
23/03/2021 24,54 24,89 23,65 23,69 -4,71% 5,05% 1.154.900
22/03/2021 25,34 25,72 24,28 24,86 +0,00% 5,68% 655.500
19/03/2021 24,13 25,18 24,06 24,86 +2,18% 4,64% 2.501.400
18/03/2021 25,71 25,82 24,15 24,33 -5,26% 6,50% 1.303.600
17/03/2021 23,91 25,73 23,30 25,68 +7,54% 10,16% 913.300
16/03/2021 24,02 25,19 23,33 23,88 -1,69% 7,74% 1.041.500
15/03/2021 22,80 24,63 22,23 24,29 +6,44% 10,53% 1.414.600
12/03/2021 20,84 22,84 20,66 22,82 +12,41% 10,46% 1.006.800
11/03/2021 19,99 20,54 19,76 20,30 +3,05% 3,90% 1.546.800
10/03/2021 20,00 20,49 19,48 19,70 +0,05% 5,05% 943.800
09/03/2021 19,57 20,37 19,34 19,69 +2,61% 5,26% 2.212.100
08/03/2021 19,76 20,20 19,14 19,19 -2,49% 5,36% 1.152.800
05/03/2021 18,66 20,02 18,00 19,68 +5,98% 10,83% 1.912.300
04/03/2021 18,26 19,12 18,04 18,57 -1,33% 5,91% 1.179.400
03/03/2021 19,36 19,98 18,56 18,82 -3,09% 7,33% 537.300
02/03/2021 19,53 19,94 19,05 19,42 -1,22% 4,56% 607.800
01/03/2021 19,24 20,09 18,77 19,66 +4,97% 6,86% 1.078.800
26/02/2021 19,51 20,36 18,34 18,73 -5,64% 10,35% 4.026.800
25/02/2021 20,60 21,46 19,64 19,85 -4,34% 8,83% 516.700
24/02/2021 20,14 20,79 20,09 20,75 +2,42% 3,48% 552.300
23/02/2021 20,48 21,11 20,07 20,26 -1,79% 5,08% 781.000
22/02/2021 21,05 21,48 20,55 20,63 -3,05% 4,42% 523.400
19/02/2021 21,18 22,48 21,17 21,28 +1,29% 6,19% 1.192.300
18/02/2021 22,82 22,82 20,99 21,01 -3,89% 8,02% 1.116.400
17/02/2021 20,90 22,24 20,42 21,86 +4,59% 8,71% 475.900
16/02/2021 22,00 22,12 20,57 20,90 -5,56% 7,05% 977.600
12/02/2021 23,07 23,07 21,97 22,13 -2,77% 4,77% 422.500